Ledger.Open graph →
SEC Form D · filed December 2, 2021

Cambrian BioPharma Inc

Offering
$100.8M
Sold
$92.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Maryanna G. Saenko · New York, NYDirectorChristian G. Angermayer · New York, NYDirectorJames G. Peyer · New York, NYExec · Director · PromoterTravis Kell · Santa Monica, CAExec · Director · PromoterAnton Zietsman · Santa Monica, CADirectorAron Shapiro · Encinitas, CADirectorJeffery C. Schneider · MOORESTOWN, NJExec · Director · PromoterRobert S. Newell · Las Vegas, NVDirectorMatthew Gaylord · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗